Background Image
Table of Contents Table of Contents
Previous Page  15 / 68 Next Page
Information
Show Menu
Previous Page 15 / 68 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 31, No 2, March/April 2020

AFRICA

67

All subjects had grade A oesophagitis in both the ACS and

the GORD group. There was no chest pain on acid instillation

among the subjects with isolated GORD and the controls. Mild

retrosternal chest pain developed in two subjects in the ACS

group but this was short lived and did not require nitroglycerin,

nor was it associated with ECG changes.

During acid installation, ECG recording showed 8/39 (20.5%)

subjects in the ACS group developed ST depression indicative

of ischaemia, compared to 5/20 (25%) patients with GORD,

and none of the controls (Fig. 2). There was no difference in

the prevalence of ST depression occurring with acid instillation

(Table 3) in the ACS compared to the GORD patients (

p

=

0.958). The odds ratio of developing ST changes after acid

installation in ACS compared to GORD patients was 1.06 (95%

CI: 0.3166–3.5411,

p

=

0.9261).

Baseline characteristics were similar in subjects with and

without ST depression. Significant ventricular arrhythmias

(Lown grade 4) were recorded in one subject in the ACS group

during acid instillation compared to none in the GORD subjects

(Table 4) (

p

=

0.001). This patient did not have ST changes

indicative of ischaemia.

Discussion

It is estimated that about 30% of subjects undergoing coronary

angiography in the USA have normal epicardial coronary

arteries and in these individuals, oesophageal diseases may

account for the symptoms in 18 to 56%.

14

Chest pain arising from

the oesophagus may be indistinguishable from angina pectoris,

since patients may present with similar symptoms and only

subtle differences.

The clinical history does not always enable a physician to

distinguish accurately between cardiac and oesophageal causes

of chest pain. Symptoms suggestive of cardiac ischaemia are

typically effort-induced pain that radiates to the arm and is

Table 2. Demographic data and baseline risk-factor profile

ACS

GORD

Control

p

-value

F

(n

=

9

)

M

(

n

=

30)

Total

(n

=

39

)

F

(n

=

15

)

M

(n

=

5

)

Total

(n

=

20

)

F

(n

=

14

)

M

(n

=

8

)

Total

(n

=

22

)

ACS vs

GORD

GORD

vs control

ACS

vs control

Age

52

51

52

±

9

49

49

49

±

12

48

44

46

±

12

0.651

0.002

0.266

Waist (cm)

93.3

93.7 94.0

±

1.9 94.9

99.5 96.0

±

1.8 85.7

78.9 83.5

±

9.1

0.702

0.030

0.002

Waist/hip

0.93

1.0 0.9

±

0.1 0.9

0.9

0.90

0.8

0.9

0.90

0.037

0.030

<

0.001

BMI (kg/m

2

)

26.1

24.2 24.7

±

4.0 29.3

25.8 28.4

±

5.5 26.3

21.0 24.4

±

4.5

0.009

0.014

0.974

Diabetes

6 (15.4) 11 (28.2) 17 (43.6)

1 (5.0)

1 (5.0)

2 (10)

0

0

0

0.001

0.597

0.031

Hypertension

5 (13.0) 12 (30.1) 17 (43.6)

1 (5.0)

0

1 (5)

0

0

0

0.002

0.294

<

0.001

History of smok-

ing

3 (7.7)

17 (43.6) 20 (51.2) 3 (15.0)

3 (15.0)

6 (30.0)

2 (9.0)

3 (13.6)

5 (22.7)

0.006

0.133

<

0.001

SBP (mmHg)

122

123 123

±

15.7 117

123 117

±

11.7 117

113 120

±

11.0

0.198

0.661

0.706

DBP (mmHg)

74

74

74

±

9.3

71

75

65

±

6.0

70

69

64

±

5.0

<

0.001

0.917

<

0.001

Plasma glucose

(mmol/l)

5.8

8.7 7.9

±

3.4 4.3

5.2 4.5

±

0.61 4.3

4.3

4.3

±

0.4

<

0.001

0.972

<

0.001

Serum cholesterol

(mmol/l)

6.9

5.0 5.9

±

2.5 5.1

4.9

5.1

±

0.9

5.0

4.0

4.3

±

0.5

0.296

0.325

0.010

Serum HDL-C

(mmol/l)

1.0

1.0 0.9

±

0.2 1.1

1.1

1.1

±

0.2

1.3

1.6

1.4

±

0.6

0.068

0.087

<

0.001

Serum LDL-C

(mmol/l)

2.6

3.0 3.0

±

1.2 2.3

2.2

2.2

±

0.7

2

1.6

1.8

±

0.5

0.176

0.121

0.028

Serum triglycer-

ides (mmol/l)

2.2

1.7 2.0

±

0.3 1.4

1.2

1.4

±

0.2

1.0

1.0

1.0

±

0.9

0.008

0.119

<

0.001

ACS, acute coronary syndrome; GORD, gastro-oesophageal disease; F, female; M, male; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C,

high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol. Figures in brackets denote percentages.

Table 3. ST changes after acid instillation

ST depression

ACS

(n

=

39)

GORD

(n

=

20)

Control

(n

=

22)

ACS vs GORD

p-value

Female,

n

(%)

3 (7.7)

4 (20)

0

Male,

n

(%)

5 (12.8)

1 (5)

0

Total,

n

(%)

8 (20.5)

5 (25)

0

0.958

Compared to the controls, ST changes were more frequently recorded in ACS

(

p

=

0.010) and GORD (

p

=

0.014) subjects. No differences were observed in ST

changes between ACS and GORD (

p

=

0.958) subjects.

ACS, acute coronary syndrome; GORD, gastro-oesopheageal reflux disease.

Fig. 2.

ST changes induced by acid instillation in an ACS

patient. Normal baseline ECG (A) followed by horizon-

tal ST depression (B). There was no accompanying

chest pain.

A

B